Three tests of small intestinal function were performed at 3100m and 4846 m to seek evidence ofmalabsorption ofhigh altitude. Xylose tolerance did not change in 11 subjects but, in three who ascended to 5600 m, one-hour xylose levels were significantly lower. The results of an oxalate loading test did not suggest significant fat malabsorption. A direct fat absorption test using chylomicron levels after ingestion of 100 g fat showed significantly increased levels at high altitude. We conclude that there is no evidence of malabsorption up to 4846 m.
Introduction
Weight loss at high altitude is well documented. Dietary intake of carbohydrate, protein and fat is often reduced.' Daily calorie intake on the Amree expedition showed a 25% reduction at 6300 m, when compared with sea level. However, weight loss did not appear to be explained by reduced dietary intake or increased energy expenditure alone and a further factor might be intestinal malabsorption secondary to hypoxia. There are few studies of gut function at high altitude, although there is some anecdotal evidence to suggest that malabsorption does occur. Xylose absorption was studied during the Amree expedition when it was found that six of seven members showed a significant reduction.
We have performed three tests of intestinal absorption during ascent to high altitude; namely xylose absorption, an oxalate load test and a measurement of chylomicrons after food.
Subjects and methods
Nine to fourteen normal subjects were studied during a walking ascent over 11 days to high altitude.2 Subjects had been allocated randomly to placebo or acetazolamide 500 mg/day as indicated in the figures.
Tests of absorption were performed at 3100 m and at 4846 m. These tests consisted of: (i) a one-hour plasma xylose estimation after an oral load. (The lower limit of normal is 0.64 mmol/l.) (ii) The oxalate loading test was performed on the following two days. All subjects were given 600 mg of sodium oxalate daily, taken with meals, for two days. During the second day a 24 hour urine collection was made, the volume noted and a 20 ml aliquot stored with sodium azide. There were no dietary restrictions during the test. All specimens were stored at ambient temperature until assayed in Birmingham 4-6 weeks later. Oxalate concentrations were assayed using a standard kit (Sigma). Where possible, the excretion rates per 24 hours and oxalate: creatinine ratios were obtained.
Chylomicrons were estimated using a nephelometer.4 Statistical analyses were performed using paired t tests. Not all samples collected arrived intact and therefore sample numbers vary for each test.
Results

Xylose absorption
Fourteen subjects had paired samples suitable for analysis. At 3100m all plasma levels were within the normal range. At 4846m all but three subjects had xylose levels within the normal range and unchanged from the levels observed at 3100m. The three other subjects had markedly reduced I-hour xylose levels ( Figure 1 
Fat absorption
Twelve samples were suitable for the chylomicron assay ( Figure 2 ). All but three showed an increased level at the higher altitude (P <0.05). There was a marked rise in four subjects in the acetazolamide group but much smaller changes in all the other subjects.
Only nine pairs of results were available for evaluation of oxalate excretion. This showed marked variation at 3100 m with seven out ofnine subjects excreting levels of more than 0.44 mmol/24 hours ( Figure 3 ). Oxalate excretion fell significantly at the higher altitude (P < 0.05) where only four out of nine subjects excreted more than 0.44 mmol/24 hours. In only one subject did oxalate excretion rise at 4846 m. In fourteen pairs of samples it was possible to relate oxalate excretion to creatinine excretion ( Figure 4) . Nine subjects had a rise in oxalate: creatinine ratio at altitude, in four the ratio fell and in one the ratio stayed constant. These differences were not sig- 
